Skip to main content
. Author manuscript; available in PMC: 2024 Jan 4.
Published in final edited form as: J Drug Issues. 2022 Aug 2;53(2):296–320. doi: 10.1177/00220426221109948

Table 3.

Chi-Square Test Results For Availability Of MAT By Medicaid Expansion States.

Medicaid Expansion State
Yes No n
Dependent variables
Buprenorphine/Naloxone film strips 70%* 30% 520
Buprenorphine injections 73%** 27% 520
Buprenorphine pills 70%* 30% 520
Disulfiram/Antabuse 78%*** 22% 520
Methadone 71%** 29% 520
Naltrexone/Vivitrol 67% 33% 520
*

p<.05

**

p <.01

***

p <.001.